Skip to main content
Clinical Trials/NCT01748617
NCT01748617
Completed
Not Applicable

The Potential for Pomegranate Juice to Ameliorate Endothelial Dysfunction

Janet Novotny1 site in 1 country12 target enrollmentDecember 2012
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Janet Novotny
Enrollment
12
Locations
1
Primary Endpoint
Change in endothelial function
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This study will be a randomized, double-blind, crossover intervention to investigate the health effects of acute ingestion of pomegranate juice when consumed with a high fat meal. After one week of controlled dietary intervention, subjects will consume a high fat morning meal supplemented with either pomegranate juice or a juice-free sweetened beverage. After consumption of the breakfast meal, subjects will be assessed for endothelial function and postprandial meal response.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
January 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Janet Novotny
Responsible Party
Sponsor Investigator
Principal Investigator

Janet Novotny

Principal Investigator

USDA Beltsville Human Nutrition Research Center

Eligibility Criteria

Inclusion Criteria

  • Men and women between the ages of 25-70 years
  • Body mass index (BMI) ≥ 19 and ≤ 38
  • Willingness and ability to make scheduled appointments at clinical site as required by study protocol

Exclusion Criteria

  • Known (self-reported) allergy or adverse reaction to study foods
  • Presence of kidney disease, liver disease, gout, untreated or unstable hyperthyroidism, untreated or unstable hypothyroidism, certain cancers, gastrointestinal disease, pancreatic disease, other metabolic diseases, or malabsorption syndromes
  • Type 2 diabetes requiring the use of oral antidiabetic agents or insulin
  • Fasting triglycerides \> 300 mg/dL
  • Fasting glucose \> 126 mg/dL
  • Use of cholesterol lowering medication
  • Blood pressure \> 180/100 or hypertension treated with calcium channel blockers, direct acting vasodilators, or beta blockers
  • Fingernails longer than 0.25 inch beyond the finger tip, or unwillingness to cut fingernails to this length during endothelial function testing
  • History of bariatric or certain other surgeries related to weight control
  • History of major surgery within 3 months of enrollment

Outcomes

Primary Outcomes

Change in endothelial function

Time Frame: 0 hour and 3 hour

After a consuming controlled diet for 1 week, subjects will report in the morning after a 12 hour fast. Upon arrival , subjects' endothelial function will be assessed by measuring endothelium-dependent flow mediated dilation of the peripheral bed (EndoPAT, Itamar Medical, Israel). For this test, subjects will rest in the supine position with a brachial blood pressure cuff on one arm and a finger tip probe on each of two fingers (one on the left hand, one on the right hand). After 5 minutes of rest, the blood pressure cuff will be inflated and remain inflated for 5 minutes. Then the cuff pressure will be released and the subject will remain resting for 5 additional minutes. This test will be repeated 3 hours after the test meal.

Study Sites (1)

Loading locations...

Similar Trials